Single Pass Announces Successful Initiation of Clinical Evaluation – QNT Press Release


LAKE FOREST, Calif., Sept. 16, 2022 /PRNewswire/ — CEO of Single Pass, Inc., Bill Coloneannounced the initiation of the clinical evaluation for the Kronos Electrocautery device designed to improve the safety of co-axial biopsy procedures. The single-use, disposable device uses battery current to heat the probe tip to cauterize the tissue damaged by the biopsy tools to prevent bleeding. Successful liver and renal biopsy procedures were completed with Duplex ultrasound and CT imaging confirmation of total tissue channel cauterization with no evidence of bleeding. The procedures were performed under the guidance of Dainis KrievinsMD, PhD, Professor and Director: Institute of Research at Pauls Stradins Clinical University Hospital in Riga Latvia.

Full story available on Benzinga.com



Source link

Recommended For You

About the Author: News Center